Aptose Biosciences (APTO) announced that Nasdaq has granted the company’s request for an extension to evidence compliance with all applicable criteria for continued listing on Nasdaq.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APTO: